The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Calpol Six Plus 250mg/5ml Oral Suspension

Johnson & Johnson (Ireland) LimitedPA0330/017/002

Main Information

Trade NameCalpol Six Plus 250mg/5ml Oral Suspension
Active SubstancesParacetamol
Dosage FormOral suspension
Licence HolderJohnson & Johnson (Ireland) Limited
Licence NumberPA0330/017/002

Group Information

ATC CodeN02BE Anilides
N02BE01 paracetamol


License statusAuthorised
Licence Issued25/01/1995
Legal statusProduct not subject to medical prescription
Supply StatusSupply through non-pharmacy outlets and pharmacies
Advertising StatusAdvertising to the general public
Conditions of LicenceGeneral Sale: MAXIMUM PACK SIZE 60ml. Maximum one pack per sale.Contains only paracetamol as analgesic. Pharmacy only: MAXIMUM PACK SIZE 140ml for product for children aged 6 – 12 years. MAXIMUM PACK SIZE 240ml if not for use in under 12’s. Maximum two packs per sale. Promotion to the public: Pack size not more than 240ml
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back